Investing

What Is Driving the Digital Health VC Rebound in 2026?
Technology What Is Driving the Digital Health VC Rebound in 2026?

A Renewed Era of Confidence in Health Technology The digital health sector has surged into the current year with a level of financial intensity that suggests the tentative days of market correction are firmly in the rearview mirror. After a period defined by cautious capital deployment, the first

Visa Policy Changes Threaten US Hospital Financial Stability
Business Visa Policy Changes Threaten US Hospital Financial Stability

The modern American hospital is an intricate machine that relies on a constant influx of specialized global talent to keep its engines running, yet this vital pipeline is currently facing unprecedented friction. As federal immigration mandates tighten, the clinical continuity of major medical

Can Yuzu Health Modernize Health Insurance Infrastructure?
Business Can Yuzu Health Modernize Health Insurance Infrastructure?

The American healthcare landscape is currently haunted by a ghost in the machine: a staggering 25% of all national health spending is drained by administrative friction before a single patient is even seen. While medical technology has leaped forward into the realm of gene editing and robotic

Neurocrine to Acquire Soleno Therapeutics for $2.9 Billion
Business Neurocrine to Acquire Soleno Therapeutics for $2.9 Billion

The biopharma landscape is shifting as major players consolidate their positions in the rare disease market, and few experts understand this evolution better than Faisal Zain. With his deep background in medical technology and the manufacturing of diagnostic and treatment devices, Faisal offers a

Medical Tourism Market Set to Reach $170 Billion by Mid-2030s
Business Medical Tourism Market Set to Reach $170 Billion by Mid-2030s

The borders of modern healthcare are dissolving as patients increasingly seek high-quality medical interventions far beyond their local zip codes, creating a seismic shift in global economic dynamics. What was once a fragmented sector defined by bargain hunting has matured into a sophisticated, $76

FDA Expands Wegovy Label to Include Heart Disease Risk Reduction
Public Policy FDA Expands Wegovy Label to Include Heart Disease Risk Reduction

The pharmaceutical landscape is currently witnessing a historic pivot as the distinction between metabolic maintenance and life-saving cardiovascular intervention begins to evaporate entirely. For decades, the medical community viewed weight-loss medications through a narrow lens of aesthetic

Loading

Subscribe to our weekly news digest

Keep up to date with the latest news and events

Paperplanes Paperplanes Paperplanes
Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later